Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Drug Chem Toxicol ; 40(3): 326-332, 2017 Jul.
Article in English | MEDLINE | ID: mdl-27600436

ABSTRACT

Flurbiprofen (FLB) (anti-inflammatory and analgesic drug) and roxithromycin (RXM) (antibiotic) were widely used in world wide. This study deals with investigation of genotoxicity, cytotoxicity, and oxidative stress effects of a particular combination of these drugs in human cultured lymphocytes. Also, DNA damaging-protective effects of combination of these drugs were analyzed on plasmid DNA. Human lymphocytes were treated with different concentrations (FLB + RXM; 10 µg/mL + 25 µg/mL, 15 µg/mL + 50 µg/mL, and 20 µg/mL + 100 µg/mL) of the drugs following by study of their genotoxic and cytotoxic effects by analysis of cytokinesis-block micronucleus test and nuclear division index, respectively. The effect of the combination in aspect of anti-oxidative and DNA damaging activity was evaluated on Pet-22b plasmid. According to our results, the combination of FLB and RXM did not show a notable genotoxic effect on cells. Although each of the substances had been shown as a cytotoxic agent by previous researchers, in this research, the combination of these drugs did not exhibit any adverse effect on cell division. FLB had DNA protection effect against H2O2 while in combination with RXM had not the same effect on the plasmid.


Subject(s)
Anti-Bacterial Agents/toxicity , Anti-Inflammatory Agents, Non-Steroidal/toxicity , DNA Damage , Flurbiprofen/toxicity , Roxithromycin/toxicity , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/pharmacology , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Cell Division/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Drug Interactions , Female , Flurbiprofen/administration & dosage , Flurbiprofen/pharmacology , Humans , Lymphocytes/drug effects , Lymphocytes/pathology , Male , Micronuclei, Chromosome-Defective/chemically induced , Oxidative Stress/drug effects , Plasmids , Roxithromycin/administration & dosage , Roxithromycin/pharmacology , Young Adult
2.
Drug Chem Toxicol ; 39(3): 307-11, 2016.
Article in English | MEDLINE | ID: mdl-26634952

ABSTRACT

4-Methylimidazole (4-MEI) is formed during the production of certain caramel coloring agents used in many food and drink products. It may also be formed during the cooking, roasting, or other processing of some foods and beverages. So it was unintentionally consumed in worldwide. This study was aimed to investigate the genotoxic and cytotoxic effects of 4-MEI using chromosome aberration (CA) and mitotic index (MI) in Swiss Albino mice. In this research, CA and MI of the mouse bone marrow cells were analyzed after treating the animals with 4-MEI (100, 130 and 160 mg/kg) for 12 h and 24 h treatment times. All data were analyzed using statistical methods. 4-MEI significantly increased the percentage of CAs at all concentrations for 12 h and at highest concentration for 24 h treatment periods. 4-MEI at highest concentration for 12 h and at all concentrations for 24 h decreased the MI in comparison with control. Genotoxic and cytotoxic effects of 4-MEI at 24 h treatment periods were concentration dependent. Consequently, it can be said that 4-MEI have genotoxic and cytotoxic effect in mouse.


Subject(s)
Bone Marrow Cells/drug effects , Chromosome Aberrations/chemically induced , Imidazoles/toxicity , Animals , Bone Marrow Cells/pathology , Cell Survival/drug effects , Dose-Response Relationship, Drug , Female , Male , Maximum Tolerated Dose , Mice , Mitotic Index
3.
Drug Chem Toxicol ; 38(3): 266-71, 2015.
Article in English | MEDLINE | ID: mdl-25156279

ABSTRACT

Remeron (Mirtazapine) is an antidepressant drug which exerts its action by blocking presynaptic α-2-adrenergic receptors and postsynaptic serotonin types 2 and 3 receptors. In this in vitro analysis, human peripheral blood lymphocytes was treated by remeron (10, 25, 40 and 55 µg/mL) for 24 hours and 48 hours periods, then it was attempted to study of genotoxic and cytotoxic effects of the substance on human peripheral blood lymphocytes by some tests such as sister chromatid exchange (SCE), chromosomal abnormalities (CA) and micronucleus (MN) tests. Also proliferating effect of the substance was investigated. Remeron didn't significantly cause chromosomal abnormalities and sister chromatid exchange while caused micronucleus at 40 µg/mL concentration and 24 h periodic time and increased proliferation index of the both 24 and 48 hours treated cells was decreased in a concentration manner. Also, exposing to the remeron for 24 and 48 hours leaded to a decrease in mitotic index and nucleus division index in the cells by concentration dependent manner. These findings showed that remeron did not have significantly genotoxic effects on human peripheral blood lymphocytes while it showed cytotoxic effects on the cells, which is the first report on genotoxic and cytotoxic properties of remeron.


Subject(s)
Adrenergic alpha-Antagonists/toxicity , Lymphocytes/drug effects , Mianserin/analogs & derivatives , Micronuclei, Chromosome-Defective/chemically induced , Serotonin Antagonists/toxicity , Sister Chromatid Exchange/drug effects , Adult , Cell Proliferation/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Female , Humans , Lymphocytes/pathology , Male , Mianserin/toxicity , Micronucleus Tests , Mirtazapine , Mitosis/drug effects , Mitotic Index , Risk Assessment , Time Factors , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...